The NIDA Animal Genomics Program aims to identify genetic variants influencing addictive behaviors, SUD stages, associated behaviors, and comorbidities through genomics approaches.
This grant supports early stage investigators proposing innovative, high-risk research on the biological and behavioral mechanisms underlying substance use disorders.
The Clinical Research Grants Program from the National Academy of Neuropsychology funds research on health disparities and cognitive outcomes in clinical neuropsychology, emphasizing innovative and early-stage studies.
NIDA's START Program offers seed funding for early-stage projects integrating substance use research with fields like drug development, brain imaging, neurocognitive tools, data science, or HIV/AIDS research.
NIMH will fund UC Santa Cruz to renew a center that standardizes and shares data on genes linked to psychiatric and neurodevelopmental disorders, supporting AI-driven research and broad biomedical use.